Sunday, November 8, 2026

GBP/EUR Over 2% Down In The Last 21 Sessions

ViaNews Editorial Team

November 16, 2023

GBP/EUR Over 2% Down In The Last 21 Sessions

(VIANEWS) - GBP/EUR (GBPEUR) has been up by 2.14% for the last 21 sessions. At 09:07 EST on Thursday, 16 November, GBP/EUR (GBPEUR) is $1.14.

GBP/EUR's yearly highs and lows, it's 2.676% up from its 52-week low and 2.863% down from its 52-week high.

Volatility

GBP/EUR's last week, last month's, and last quarter's current intraday variation average was a positive 0.04%, a negative 0.02%, and a positive 0.19%, respectively.

GBP/EUR's highest amplitude of average volatility was 0.17% (last week), 0.19% (last month), and 0.19% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, GBP/EUR's Forex is considered to be oversold (<=20).

News about

  • Usd/jpy declines after soft US cpi, falling yields. According to FXStreet on Tuesday, 14 November, "On Tuesday, the USD/JPY fell sharply towards the 150.90 area, seeing nearly 0.50% losses. ", "On the daily chart, the USD/JPY has a neutral to bearish bias with a consolidation phase underway, suggesting that the buyers are regrouping after a six-day winning streak. "
  • Usd/jpy technical analysis: amid stability around the highest level in A year - 14 November 2023. According to DailyForex on Tuesday, 14 November, "In this regard, Valentin Marinov, Forex analyst at Credit Agricole, says, "The overvaluation of the USD/JPY pair has increased to approximately two standard deviations. ", "Therefore, if an event occurs that will change the trend of the USD/JPY currency pair to a strong bearish direction in a very short time, wherever, we do not prefer to buy with a risk from those peaks. "
  • Usd/jpy: US CPI data will be crucial to see a break of 33-year high at 151.95 – MUFG. According to FXStreet on Tuesday, 14 November, "The US CPI data will be crucial on whether USD/JPY breaks back higher and through the high from Monday and through the current cyclical high recorded in last year at 151.95, a 33-year high.", "Any Dollar strength will likely be most prevalent in USD/JPY if option-related resistance at 152.00 gives way."
  • Usd/jpy extends losses below the 20-day sma, eyes on Japanese GDP and US PPI. According to FXStreet on Tuesday, 14 November, "The USD/JPY suffered significant setbacks in Tuesday's session, falling towards the trajectory of the pair being set by soft CPI data from the US. ", "The USD/JPY displays a neutral to bearish technical bias on the daily chart, with signals suggesting that the bears are gaining ground. "

More news about GBP/EUR (GBPEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Season: Regulatory Deadlines and Data Readouts Against Cost Discipline and Slipping Timelines
From late October 2026 to January 2027, mid-cap biotechs cluster pivotal data presentations (ESMO, AHA, AASLD), FDA decision dates (ivonescimab BLA on 2026-11-14, lorundrostat on 2026-12-22) and Q3 earnings. Alongside these, several companies are managing capital: lowering R&D and SG&A guidance, pushing clinical milestones into 2027, authorizing a $400M buyback, and pursuing a delisting. Late-stage programs in oncology, hepatitis delta, hypertension and women's health look near commercial inflection, while cost cuts and delays point to uneven balance-sheet strength.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,552 source documents archived
Query this data → isubstrate.com